ARHGAP39

ARHGAP39 (Vilse/CrossGAP) is a RhoGAP that inactivates Rac and, less efficiently, Cdc42 and RhoA by stimulating GTP hydrolysis, functioning as a key effector of cytoskeletal remodeling downstream of Slit-Robo repulsive signaling and during neuronal morphogenesis. ARHGAP39 directly binds the intracellular domain of the Robo receptor and transduces repulsive axon guidance signals by locally inactivating Rac (PMID:15342493, PMID:15755809). In mammalian hippocampal neurons, ARHGAP39 is constitutively scaffolded by CNK2 via its WW domains, and this interaction is required for proper Rac GDP/GTP cycling during dendritic spine formation (PMID:24656827). Forebrain-specific loss of ARHGAP39 in mice reduces spine density, impairs hippocampal synaptic plasticity (LTP), and causes spatial memory deficits, establishing its requirement for dendritic architecture and higher cognitive function (PMID:28368047).

1. 2004 High

   The identification of Vilse as a direct Robo-binding RhoGAP that preferentially inactivates Rac resolved how Slit-Robo repulsive signaling is transduced into cytoskeletal changes at the midline.

   Evidence Direct pull-down, in vitro GAP assays, and genetic epistasis with robo/slit/rac in Drosophila

   PMID:15342493

   Open questions at the time

   • Structural basis of the Vilse–Robo interaction unknown
   • Relative contributions of Rac versus Cdc42 inactivation to midline repulsion unresolved
   • Mammalian relevance of the Robo–Vilse axis not yet tested
2. 2005 High

   Independent replication confirmed the Vilse–Robo physical association and placed CrossGAP/Vilse genetically between Robo and Rac in repulsive guidance, solidifying the pathway model.

   Evidence Reciprocal co-immunoprecipitation and dosage-sensitive genetic interactions in Drosophila

   PMID:15755809

   Open questions at the time

   • Whether Vilse is the sole GAP downstream of Robo or acts redundantly with other GAPs unclear
   • Regulation of Vilse recruitment to Robo (e.g., phosphorylation-dependent) unknown
3. 2014 High

   Discovery that CNK2 constitutively scaffolds ARHGAP39 via WW-domain/proline-motif contacts and that this complex controls Rac cycling during spine morphogenesis revealed a mammalian spatial regulation mechanism for ARHGAP39's GAP activity.

   Evidence Mass spectrometry, co-immunoprecipitation, domain-mapping mutagenesis, and spine morphology rescue in rat hippocampal neurons

   PMID:24656827

   Open questions at the time

   • Whether Robo-dependent and CNK2-dependent pools of ARHGAP39 overlap or are functionally distinct is unknown
   • Upstream signals that modulate the CNK2–ARHGAP39 complex not identified
   • Stoichiometry and structural details of the CNK2–ARHGAP39 complex unresolved
4. 2017 High

   Conditional knockout of ARHGAP39 in the mouse forebrain established that its GAP activity is required in vivo for dendritic complexity, spine density, hippocampal LTP, and spatial memory, moving the gene from a guidance effector to a regulator of synaptic plasticity.

   Evidence Camk2a-Cre conditional KO, Golgi staining, electrophysiology, Morris water maze and Y-maze

   PMID:28368047

   Open questions at the time

   • Whether the synaptic phenotype reflects Rac, RhoA, or Cdc42 dysregulation specifically is unresolved
   • Cell-type-specific requirements beyond excitatory CA1 neurons not examined
   • No human genetic disease link yet established
5. 2025 Medium

   Reconstitution of purified ARHGAP39 confirmed dual GAP activity toward both RhoA and Rac1 in vitro and implicated loss of ARHGAP39 in hepatocellular carcinoma cell migration, broadening its known substrate range and linking it to cancer-relevant phenotypes.

   Evidence In vitro GTPase assay with recombinant protein, CRISPR-Cas9 knockout in HCC cell lines, migration/invasion assays, RNA-seq

   PMID:39866228

   Open questions at the time

   • Single-lab finding; RhoA GAP activity in a cellular context not independently confirmed
   • Causal role of MMP13/LAMB1 upregulation downstream of ARHGAP39 loss not tested
   • In vivo tumor model validation absent

• Key unresolved questions include the structural basis of ARHGAP39 substrate selectivity across Rac1, Cdc42, and RhoA, the signals that regulate its localization or activity in neurons versus non-neuronal contexts, and whether ARHGAP39 mutations cause human neurological or developmental disease.
• No crystal or cryo-EM structure of the GAP domain with any substrate
• Post-translational regulation (phosphorylation, ubiquitination) of ARHGAP39 unexplored
• No human genetic studies linking ARHGAP39 variants to Mendelian or neurodevelopmental disorders